New Triple-Threat treatment aims to shrink lung tumors before surgery
NCT ID NCT06877299
Summary
This study is testing a three-part treatment given before surgery for patients with certain stages of non-small cell lung cancer. The goal is to see if combining low-dose radiation, a targeted high-dose radiation, chemotherapy, and an immunotherapy drug can better shrink or eliminate the tumor before it is surgically removed. Researchers will measure how many patients have no detectable cancer cells left in the removed tumor and lymph nodes after this pre-surgery treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital of Sichuan University
RECRUITINGChengdu, China, 610041, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.